-
1
-
2
Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial.
Published 2015“…The combination of lamotrigine plus quetiapine potentially offers improved outcomes for people with bipolar depression. …”
Journal article -
3
-
4
Comparative efficacy and acceptability of antimanic drugs in acute mania: A multiple-treatments meta-analysis
Published 2011“…Olanzapine, risperidone, and quetiapine led to significantly fewer discontinuations than did lithium, lamotrigine, placebo, topiramate, and gabapentin. …”
Journal article -
5
Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis.
Published 2011“…Olanzapine, risperidone, and quetiapine led to significantly fewer discontinuations than did lithium, lamotrigine, placebo, topiramate, and gabapentin. …”
Journal article -
6
Biochemical and genetic predictors and correlates of response to lamotrigine and folic acid in bipolar depression: Analysis of the CEQUEL clinical trial
Published 2017“…<p><strong>Objectives</strong> CEQUEL (Comparative Evaluation of QUEtiapine plus Lamotrigine combination versus quetiapine monotherapy [and folic acid versus placebo] in bipolar depression) was a double‐blind, randomized, placebo‐controlled, parallel group, 2×2 factorial trial that examined the effect of adding lamotrigine and/or folic acid (FA) to quetiapine in bipolar depression. …”
Journal article -
7
Clinical and regulatory implications of active run-in phases in long-term studies for bipolar disorder
Published 2014“…Results: Six placebo-controlled trials comparing aripiprazole, olanzapine, quetiapine and ziprasidone were found in the FDA website. …”
Journal article -
8
Clinical and regulatory implications of active run-in phases in long-term studies for bipolar disorder.
Published 2014“…RESULTS: Six placebo-controlled trials comparing aripiprazole, olanzapine, quetiapine and ziprasidone were found in the FDA website. …”
Journal article